Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ—population-based follow-up of two cluster-randomized trials
Long-term follow-up of randomized, initially adolescent HPV-vaccinated and unvaccinated cohorts shows, in this head-to-head setting, that the bivalent and quadrivalent HPV vaccines are equally effective against immediate precursors of cervical cancer.
Authors
- Matti Lehtinen (ORCID: https://orcid.org/0000-0002-9481-0535)
- Dan Apter (ORCID: https://orcid.org/0000-0002-5175-8845)
- Jorma Paavonen (ORCID: https://orcid.org/0000-0003-4775-606X)
- Joakim Dillner (ORCID: https://orcid.org/0000-0001-8588-6506)
- Tiina Eriksson (ORCID: https://orcid.org/0000-0002-3821-9775)
- Kaisa Heikkilä
- Tiina Petäjä
- Penelope Grace Gray (ORCID: https://orcid.org/0000-0001-9065-4734)
- Ville Nikolai Pimenoff (ORCID: https://orcid.org/0000-0002-0813-7031)
- Mervi Nummela
- Tapio Luostarinen (ORCID: https://orcid.org/0000-0003-3231-8550)
- Katja Harjula
- Anne Bly
- Eero Pukkala (ORCID: https://orcid.org/0000-0001-9536-6440)
- Pekka Nieminen (ORCID: https://orcid.org/0000-0001-5671-8685)
- Johanna Palmroth
- Mari Hokkanen
- Marjo Kuortti
Institutions
- University of Helsinki (FI)
- Tampere University (FI)
- University of Eastern Finland (FI)
- Karolinska Institutet (SE)
- Finnish Cancer Registry (FI)
- VL-Medi Oy (Finland) (FI)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2024-09-09
- DOI
- https://doi.org/10.3389/fcimb.2024.1437704
- Citations
- 3
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Cancerfonden